CLINICALLY ISOLATED SYNDROME
Clinical trials for CLINICALLY ISOLATED SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CLINICALLY ISOLATED SYNDROME trials appear
Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could diet and exercise replace MS drugs? new study investigates
Disease control OngoingThis study looks at whether a healthy lifestyle—including diet, stress management, and exercise—can be as good as standard medications for managing symptoms and improving quality of life in people newly diagnosed with early multiple sclerosis (MS) or its precursor, clinically iso…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: NA • Sponsor: Terry L. Wahls • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
New study tracks Ocrelizumab's impact on MS brain fluid markers
Knowledge-focused OngoingThis study looks at how the drug ocrelizumab changes certain markers in the spinal fluid of people newly diagnosed with relapsing multiple sclerosis or a high-risk first episode. Thirty participants will receive ocrelizumab and have their spinal fluid tested before and after thre…
Matched conditions: CLINICALLY ISOLATED SYNDROME
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC